Chromosome-breakage genomic instability and chromothripsis in breast cancer

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Przybytkowski, Ewa ^a   Lenkiewicz, Elizabeth ^c   Barrett, Michael T ^c   Klein, Kathleen ^a   Nabavi, Sheida ^d   Greenwood, Celia M T ^a,b   Basik, Mark ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d Harvard Medical School Center for Biomedical Informatics   (United States)

Author keywords

Array CGH; Breast cancer; Chromosomal breakpoints; Chromothripsis; Copy number alterations; Gene amplification; Genomic instability

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BCAS3 GENE; BREAST CANCER; CANCER GRADING; CANCER PROGNOSIS; CCND1 GENE; CHROMOSOME 17; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CHROMOTHRIPSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE FREE SURVIVAL; GENE; GENE AMPLIFICATION; GENE DELETION; GENE REARRANGEMENT; GENOMIC INSTABILITY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MIDDLE AGED; ONCOGENE MYC; OVERALL SURVIVAL; PLOIDY; PVT1 ONCOGENE; TRIPLE NEGATIVE BREAST CANCER; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; GENOMICS; HUMAN CHROMOSOME; PATHOLOGY;

BREAST NEOPLASMS; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC PREDISPOSITION TO DISEASE; GENOMIC INSTABILITY; GENOMICS; HUMANS; MIDDLE AGED; NEOPLASM GRADING;

EID: 84903875223     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-579     Document Type: Article

References (33)

1. Bertos NR, Park M: Breast cancer-one term, many entities? J Clin Invest 2011, 121(10):3789-3796.
2. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature 2000, 406(6797):747-752.
3. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98(19):10869-10874.
4. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Group M, Langerod A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Borresen-Dale AL, Brenton JD, Tavare S, et al: The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486(7403):346-352.
5. Forment JV, Kaidi A, Jackson SP: Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat Rev Cancer 2012, 12(10):663-670.
6. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Carter NP, Morsberger LA, Iacobuzio-Donahue C, Follows GA, Green AR, Flanagan AM, Stratton MR, et al: Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144(1):27-40.
7. Hosein AN, Wu M, Arcand SL, Lavallee S, Hebert J, Tonin PN, Basik M: Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations. Cancer Res 2010, 70(14):5770-5777.
8. Ruiz C, Lenkiewicz E, Evers L, Holley T, Robeson A, Kiefer J, Demeure MJ, Hollingsworth MA, Shen M, Prunkard D, Rabinovitch PS, Zellweger T, Mousses S, Trent JM, Carpten JD, Bubendorf L, Von Hoff D, Barrett MT: Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci U S A 2011, 108(29):12054-12059.
9. Przybytkowski E, Ferrario C, Basik M: The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome. BMC Med Genomics 2011, 4:16.
10. Liu P, Carvalho CM, Hastings PJ, Lupski JR: Mechanisms for recurrent and complex human genomic rearrangements. Curr Opin Genet Dev 2012, 22(3):211-220.
11. Pardo B, Aguilera A: Complex chromosomal rearrangements mediated by break-induced replication involve structure-selective endonucleases. PLoS Genet 2012, 8(9):e1002979.
12. Malhotra A, Lindberg M, Faust GG, Leibowitz ML, Clark RA, Layer RM, Quinlan AR, Hall IM: Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms. Genome Res 2013, 23(5):762-776.
13. Barlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, Heiskanen M, Kallioniemi OP, Kallioniemi A: Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes Chromosomes Cancer 2002, 35(4):311-317.
14. Kwei KA, Kung Y, Salari K, Holcomb IN, Pollack JR: Genomic instability in breast cancer: pathogenesis and clinical implications. Mol Oncol 2010, 4(3):255-266.
15. Ahn SG, Lee HM, Cho SH, Bae SJ, Lee SA, Hwang SH, Jeong J, Lee HD: The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence. PLoS One 2013, 8(5):e63510.
16. Garraway LA, Lander ES: Lessons from the cancer genome. Cell 2013, 153(1):17-37.
17. Bonnet F, Guedj M, Jones N, Sfar S, Brouste V, Elarouci N, Banneau G, Orsetti B, Primois C, de Lara CT, Debled M, de Mascarel I, Theillet C, Sevenet N, de Reynies A, MacGrogan G, Longy M: An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis. BMC Med Genomics 2012, 5:54.
18. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, Yoon S, Wigler M, Ye K, Borresen-Dale AL, Naume B, Schlicting E, Norton L, Hagerstrom T, Skoog L, Auer G, Maner S, Lundin P, Zetterberg A: Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res 2006, 16(12):1465-1479.
19. Jonsson G, Staaf J, Vallon-Christersson J, Ringner M, Holm K, Hegardt C, Gunnarsson H, Fagerholm R, Strand C, Agnarsson BA, Kilpivaara O, Luts L, Heikkila P, Aittomaki K, Blomqvist C, Loman N, Malmstrom P, Olsson H, Johannsson OT, Arason A, Nevanlinna H, Barkardottir RB, Borg A: Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res 2010, 12(3):R42.
20. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, Sorlie T, Borgen E, Rye IH, Langerod A, Chin SF, Teschendorff AE, Stephens PJ, Maner S, Schlichting E, Baumbusch LO, Karesen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Borresen-Dale AL: Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci Trans Med 2010, 2(38):38ra47.
21. Zhang CZ, Leibowitz ML, Pellman D: Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev 2013, 27(23):2513-2530.
22. Kloosterman WP, Hoogstraat M, Paling O, Tavakoli-Yaraki M, Renkens I, Vermaat JS, van Roosmalen MJ, van Lieshout S, Nijman IJ, Roessingh W, van't Slot R, van de Belt J, Guryev V, Koudijs M, Voest E, Cuppen E: Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer. Genome Biol 2011, 12(10):R103.
23. Magrangeas F, Avet-Loiseau H, Munshi NC, Minvielle S: Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. Blood 2011, 118(3):675-678.
24. Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, Ebus ME, Haneveld F, Lakeman A, Schild L, Molenaar P, Stroeken P, van Noesel MM, Ora I, Santo EE, Caron HN, Westerhout EM, Versteeg R: Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012, 483(7391):589-593.
25. Rausch T, Jones DT, Zapatka M, Stutz AM, Zichner T, Weischenfeldt J, Jager N, Remke M, Shih D, Northcott PA, Pfaff E, Tica J, Wang Q, Massimi L, Witt H, Bender S, Pleier S, Cin H, Hawkins C, Beck C, von Deimling A, Hans V, Brors B, Eils R, Scheurlen W, Blake J, Benes V, Kulozik AE, Witt O, Martin D, et al: Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 2012, 148(1-2):59-71.
26. Maher CA, Wilson RK: Chromothripsis and human disease: piecing together the shattering process. Cell 2012, 148(1-2):29-32.
27. Korbel JO, Campbell PJ: Criteria for inference of chromothripsis in cancer genomes. Cell 2013, 152(6):1226-1236.
28. Rashid-Kolvear F, Pintilie M, Done SJ: Telomere length on chromosome 17q shortens more than global telomere length in the development of breast cancer. Neoplasia 2007, 9(4):265-270.
29. Shchelochkov OA, Cheung SW, Lupski JR: Genomic and clinical characteristics of microduplications in chromosome 17. Am J Med Genet A 2010, 152A(5):1101-1110.
30. Roylance R, Endesfelder D, Gorman P, Burrell RA, Sander J, Tomlinson I, Hanby AM, Speirs V, Richardson AL, Birkbak NJ, Eklund AC, Downward J, Kschischo M, Szallasi Z, Swanton C: Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol Biomarkers Prevent: Publ Am Assoc Cancer Res, cosponsored by Am Soc Prevent Oncol 2011, 20(10):2183-2194.
31. Jain AN, Chin K, Borresen-Dale AL, Erikstein BK, Eynstein Lonning P, Kaaresen R, Gray JW: Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc Natl Acad Sci U S A 2001, 98(14):7952-7957.
32. Smid M, Hoes M, Sieuwerts AM, Sleijfer S, Zhang Y, Wang Y, Foekens JA, Martens JW: Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes. Breast Cancer Res Treat 2011, 128(1):23-30.
33. Yanagawa M, Ikemot K, Kawauchi S, Furuya T, Yamamoto S, Oka M, Oga A, Nagashima Y, Sasaki K: Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype. BMC Res Notes 2012, 5:376.